Logo

Interpace Diagnostics AccuCea Insights

Aug 24, 2016

Interpace Diagnostics has launched AccuCea Insights, a diagnostic testing service that aids in diagnosing and treating pancreatic cancer. The service provides physicians with additional information on how to compare diagnostic test results to those of other patients through Interpace's database of over 15,000 patients, the company said. Once reports are delivered to ordering physicians, they have an opportunity to speak with one of the company's molecular pathologists to discuss the potential benefits of conducting a full, molecular pathology review.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.